BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1584138)

  • 21. Dose parameters of 125I and 192Ir seed sources.
    Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
    Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study.
    Luxton G
    Med Phys; 1994 May; 21(5):631-41. PubMed ID: 7935197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-dimensional dose distribution of 125I seeds.
    Ling CC; Schell MC; Yorke ED; Palos BB; Kubiatowicz DO
    Med Phys; 1985; 12(5):652-5. PubMed ID: 4047002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose distribution along the transverse axis of a new 125I source for interstitial brachytherapy.
    Nath R; Yue N
    Med Phys; 2000 Nov; 27(11):2536-40. PubMed ID: 11128306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry of 125I sources in a low-density material using scaling.
    Rashid H; Bjarngard BE; Chin LM; Rice RK
    Med Phys; 1993; 20(3):765-8. PubMed ID: 8350834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of solid phantoms with water for dosimetry of 125I brachytherapy sources.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1988; 15(5):695-701. PubMed ID: 3185404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accuracy of single-seed dose superposition for I-125 implants.
    Burns GS; Raeside DE
    Med Phys; 1989; 16(4):627-31. PubMed ID: 2770634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism.
    Wallace RE; Fan JJ
    Med Phys; 1998 Nov; 25(11):2190-6. PubMed ID: 9829244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetry and physical treatment planning for iodine eye plaque therapy.
    Alberti W; Pothmann B; Tabor P; Muskalla K; Hermann KP; Harder D
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1087-92. PubMed ID: 2022510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M; Rogers DW
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental determination of dosimetry parameters for Sinko (125)I seed source using a modified polystyrene phantom.
    Duan Y; Zhang M; Wang G; Du L
    Australas Phys Eng Sci Med; 2012 Sep; 35(3):291-6. PubMed ID: 22766686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; PĂ©rez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.